Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China
· Delayed Price · Currency is CNY 132.50
-1.50 (-1.12%)
Mar 10, 2026, 9:25 AM CST
Beijing Hotgen Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | -191 | 28.92 | 944.74 | 2,186 | Upgrade
|
| Depreciation & Amortization | - | 89.05 | 70.53 | 120.29 | 68.34 | Upgrade
|
| Other Amortization | - | 15.77 | 7.76 | 28.15 | 5.38 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 1.63 | 0.64 | 0.34 | 14.21 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 55.15 | 36.95 | 70.06 | 8.51 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 9.36 | 23.68 | -10.91 | -24.88 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 1.36 | -13.4 | 11.34 | 0.7 | Upgrade
|
| Other Operating Activities | - | 24.39 | -59.57 | 94.17 | 118.58 | Upgrade
|
| Change in Accounts Receivable | - | -77.16 | 93.75 | -22.28 | -81.52 | Upgrade
|
| Change in Inventory | - | 47.59 | 123.21 | 36.03 | -213.43 | Upgrade
|
| Change in Accounts Payable | - | 3.31 | -284.98 | -242.99 | 564.77 | Upgrade
|
| Change in Other Net Operating Assets | - | -24.34 | -71.27 | -32.27 | 8.46 | Upgrade
|
| Operating Cash Flow | - | -37.16 | -48.53 | 978.75 | 2,644 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -62.99% | 1506.38% | Upgrade
|
| Capital Expenditures | - | -51.41 | -413.37 | -565.21 | -398.86 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 1.19 | 3.74 | 0.58 | 0.13 | Upgrade
|
| Divestitures | - | -7.89 | -17.11 | -0.08 | - | Upgrade
|
| Investment in Securities | - | 130.21 | 238.61 | -602.42 | -1,367 | Upgrade
|
| Other Investing Activities | - | 38.74 | 26.56 | 17.08 | 22.34 | Upgrade
|
| Investing Cash Flow | - | 110.83 | -161.57 | -1,130 | -1,763 | Upgrade
|
| Long-Term Debt Repaid | - | -5.12 | -27.24 | -32.29 | -11.4 | Upgrade
|
| Total Debt Repaid | - | -5.12 | -27.24 | -32.29 | -11.4 | Upgrade
|
| Net Debt Issued (Repaid) | - | -5.12 | -27.24 | -32.29 | -11.4 | Upgrade
|
| Issuance of Common Stock | - | 45.02 | 3.34 | - | - | Upgrade
|
| Repurchase of Common Stock | - | -92.03 | -16.44 | -150.04 | - | Upgrade
|
| Common Dividends Paid | - | -17.34 | - | -310.98 | -93.29 | Upgrade
|
| Other Financing Activities | - | -10 | 3.8 | 8.32 | 9.63 | Upgrade
|
| Financing Cash Flow | - | -79.48 | -36.55 | -484.99 | -95.07 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -0.15 | -0.46 | 5.2 | -14.83 | Upgrade
|
| Net Cash Flow | - | -5.96 | -247.11 | -631.09 | 771.69 | Upgrade
|
| Free Cash Flow | - | -88.57 | -461.9 | 413.54 | 2,246 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -81.58% | - | Upgrade
|
| Free Cash Flow Margin | - | -17.34% | -84.31% | 11.63% | 41.82% | Upgrade
|
| Free Cash Flow Per Share | - | -0.96 | -5.23 | 4.50 | 24.40 | Upgrade
|
| Cash Income Tax Paid | - | 8.39 | 20.06 | 371.82 | 312.86 | Upgrade
|
| Levered Free Cash Flow | - | 36.2 | -561.63 | 129.6 | 1,644 | Upgrade
|
| Unlevered Free Cash Flow | - | 36.48 | -561 | 131.05 | 1,645 | Upgrade
|
| Change in Working Capital | - | -42.87 | -144.05 | -279.43 | 267.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.